The 25,000-square-foot center is opening with a staff of 35, but that number is expected to double over the next two years.

In a world of increasing fragmentation and polarisation, the 78th World Health Assembly, starting Monday, will present itself ...

Health experts discussed ways to enhance the role of vaccinations in managing common chronic diseases in an ageing population ...

The global drug delivery technology market is on a transformative trajectory, projected to soar from USD 52.1 billion in 2025 to an astounding USD 136.7 billion by 2035. This reflects a robust CAGR of ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...

At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...

Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.

The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with ...